Changes

Jump to navigation Jump to search
80 bytes added ,  04:07, July 2, 2022
The FDA's approval of the unavailable Comirnaty was a classic bait-and-switch.
Line 1: Line 1: −
'''Comirnaty''' is an unavailable [[COVID vaccine]] which was approved by the [[FDA]] on August 23 to give cover to its lack of approval of the [[Pfizer]] [[vaccine]].
+
'''Comirnaty''' is an unavailable [[COVID vaccine]] which was approved by the [[FDA]] on August 23 to give cover to its lack of approval of the [[Pfizer]] [[vaccine]].  The FDA's approval of the unavailable Comirnaty was a classic bait-and-switch.
    
Comirnaty is still experimental -- the approval is contingent on studies on myocarditis with a 5-year follow-up that will not end until 2-27.
 
Comirnaty is still experimental -- the approval is contingent on studies on myocarditis with a 5-year follow-up that will not end until 2-27.
Siteadmin, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
125,657

edits

Navigation menu